80 Participants NeededMy employer runs this trial

Tirzepatide vs Semaglutide for Obesity

(JOULE3 Trial)

AL
AT
Overseen ByAaron Thomas, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Phase 4
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to determine if there are differences in the effect of 12 weeks of tirzepatide versus semaglutide on energy balance in adults with obesity and without known diabetes. The main questions it aims to answer are:

\- Does tirzepatide have a greater effect on energy expenditure or energy extraction than semaglutide?

Participants will:

* Take tirzepatide or semaglutide once weekly for 12 weeks

* Undergo identical baseline and week 12 study visits (including 24-hour whole room indirect calorimeter testing, MRI scan, body composition, 3-day meal plan and stool collection)

Who Is on the Research Team?

ZP

Zubin Punthakee, MD, MSc

Principal Investigator

McMaster University

Are You a Good Fit for This Trial?

This trial is for adults with obesity who do not have diabetes. Participants should be generally healthy aside from their weight and able to attend study visits over a 12-week period.

Inclusion Criteria

I am between 18 and 60 years old.
Body mass index (BMI) >30 kg/m2
Stable body weight (<5kg change in the 3 months prior to screening)

Exclusion Criteria

Currently pregnant/breastfeeding, previous pregnancy within the last 6 months, or unwillingness to use contraception for 3 months
Claustrophobia precluding a 24 hour stay in a whole room calorimeter or MRI scan
I have been diagnosed with diabetes.
See 17 more

What Are the Treatments Tested in This Trial?

Interventions

  • Semaglutide
  • Tirzepatide

Trial Overview

The study compares two weekly injectable medications, tirzepatide and semaglutide, over 12 weeks to see which one affects energy use and weight loss more in people with obesity. Participants are randomly assigned to one of the two treatments.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: TirzepatideExperimental Treatment1 Intervention
Group II: SemaglutideExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+